Southeastern Esthetics Institute

AUGUST 23, 2016

Having a thorough understanding of the dermatology and plastic surgery procedures, in addition to all new and modern cosmetic procedures on the market, is critical in assisting your clients in answering questions. Having daily and weekly communication when dealing with patients receiving treatment is critical.

Esthetician 195

Esthetician Esthetics Document Office 195

AAAMS

DECEMBER 19, 2024

Heres why it appeals to so many medical professionals: High Demand: Patients are increasingly seeking non-invasive cosmetic treatments, creating a steady demand for trained practitioners. Understanding patient safety protocols and treatment planning. Aesthetic medicine is one of the fastest-growing fields in healthcare.

Social Media 52

Social Media Work-Life Balance Training Microneedling 52

The Dermatology Digest

MARCH 3, 2025

.” The Unbeatable Performance campaign will feature Maher in a variety of content, including a modern recreation of the brand’s beloved girl-and-dog pose used on product packaging and in the brand’s marketing. The campaign will also include social media and online video.

Medical Grade Skincare 74

Medical Grade Skincare Social Media Branding Skin Health 74

The Dermatology Digest

MARCH 5, 2025

first pivotal Phase 3 Spongilla Treatment for Acne Research (STAR-1) trial of Xyngari, a novel, once-weekly, topical product candidate for the treatment of moderate-to-severe acne. The XYNGARI Phase 3 STAR-1 clinical study will evaluate the efficacy, safety, and tolerability of Xyngari in patients with moderate-to-severe facial acne.

Treatments 36

Treatments Rosacea Pores Office 36

The Dermatology Digest

NOVEMBER 30, 2024

Several new therapies are coming down the pike for the treatment of lichen planus, a chronic inflammatory condition that affects an estimated 1% to 2% of the global population, according to a new report from Research and Markets. Incyte is investigating the efficacy and safety of ruxolitinib cream in cutaneous lichen planus.

Pharmaceutical 36

Pharmaceutical Safety Marketing Therapy 36

Lipgloss and Aftershave

OCTOBER 30, 2024

Unlike large laser companies that spend millions on marketing with big events, influencer partnerships, and doctor endorsements, we avoid these costly strategies, which often contribute to significant price markups. Question Which of your lasers offers a “pain-free” experience for the client?

Hair Removal 52

Hair Removal Skin Types Technology Safety 52

Online Laser Training

DECEMBER 8, 2019

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

Technology 60

Technology Treatments Safety Medical 60

Online Laser Training

DECEMBER 8, 2019

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

Technology 60

Technology Treatments Safety Medical 60

Online Laser Training

DECEMBER 8, 2019

Dr Godfrey Town gave a talk on ‘ Update on Home-Use Devices: New Devices, Regulations & Safety ’ as an Invited Speaker at the new European Congress on Advanced Treatments and Technologies in Skin & Aesthetics (Skin-Med2019) annual conference held 5th to 8th December 2019 at the Holton Munich City Hotel in Germany.

Technology 60

Technology Treatments Safety Medical 60

The Dermatology Digest

JULY 24, 2024

The two companies will collaborate in sales, marketing, education, and research. market share within three years. market,” says Ethan Min, CEO of BENEV, in a news release. .” market,” says Ethan Min, CEO of BENEV, in a news release. “We Hugel Inc.’s s botulinum toxin product Letybo is coming to the U.S.

Dermatology 78

Dermatology Sales Marketing Safety 78

The Dermatology Digest

FEBRUARY 10, 2025

Food and Drug Administration (FDA) and Marketing Authorization Application (MAA) in the UK and EU for CORDStrom in Recessive Dystrophic Epidermolysis Bullosa (RDEB). This trial showed a favorable benefit-risk profile in support of the intended applications for marketing authorization. INmune Bio, Inc.

Hospital 36

Hospital Sustainability Therapy Marketing 36

AAAMS

JANUARY 21, 2025

Non-invasive body contouring treatments have gained immense popularity due to their ability to target stubborn fat, tighten skin, and improve body shape all without the need for invasive procedures. Non-invasive body contouring refers to treatments that reduce fat, tighten skin, and reshape targeted areas of the body without surgery.

Surgery 52

Surgery Technology Collagen Scarring 52

Beauty Launchpad

JANUARY 7, 2025

Magic Sleek is the first and only hair care brand on the market that has been approved by the Occupational Safety and Health Administration (OSHA), Food and Drug Administration (FDA) and European Union (EU).

Safety 52

Safety Branding Marketing Treatments 52

The Dermatology Digest

FEBRUARY 18, 2025

Just days after snagging dual approvals for moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN) in the European Union, nemolizumab (Nemluvio, Galderma) was also granted Marketing Authorization in the United Kingdom (UK) and Switzerland for AD and PN. Food and Drug Administration for the treatment of AD and PN.

Dermatitis 36

Dermatitis Marketing Hospital Clinic 36

Les Nouvelles Esthetics & Spa

FEBRUARY 29, 2024

Additionally, automated communication tools keep clients engaged and informed throughout their treatment journey, improving satisfaction and loyalty. This seamless integration of technology ensures that every aspect of the client experience is considered and optimized, from the initial consultation to post-treatment care.

Innovations 78

Innovations Management Client Safety Client Care 78

The Dermatology Digest

MARCH 3, 2025

Vyjuvek (beremagene geperpavec-svdt, or B-VEC) for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. approved by the EC, the Company expects to market B-VEC under the registered European trademark, Vyjuvek.

Therapy 36

Therapy Clinic Hospital Dermatology 36

The Dermatology Digest

APRIL 16, 2024

Food and Drug Administration (FDA) has approved Selarsdi (ustekinumab-aekn) injection for subcutaneous use as a biosimilar to Stelara for the treatment of moderate to severe plaque psoriasis and for active psoriatic arthritis in adults and pediatric patients 6 years and older. Market Access at Teva, in a news release.

Partnerships 74

Partnerships Injections Safety Marketing 74

New Age Spa Institute

DECEMBER 18, 2024

The Clinical Aesthetics Certification is 70 hours of continuing education units (CEU) and ideal for professionals aiming to work in medical spas, dermatology clinics, or with advanced skincare treatments. The curriculum includes: Combining the best of clinical and medspa treatments including microneedling, MRF, nanochanneling and more.

Medical 52

Medical Esthetics Legal Continuous Education 52

Texas Dermatology

DECEMBER 24, 2024

This non-invasive treatment uses advanced laser technology to target hair follicles, reducing regrowth and delivering lasting results. It is the most advanced laser technology on the market that can safely treat skin types I-VI. Proper training and expertise are crucial to ensure your safety and the best possible results.

Hair Removal 36

Hair Removal Waxing Moisturization Med Spa 36

The Dermatology Digest

FEBRUARY 14, 2024

Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). The FDA has granted nemolizumab Priority Review for prurigo nodularis.

Dermatitis 78

Dermatitis Clinic Safety Dermatology 78

The Beauty Brains

MAY 13, 2019

The Beauty Brains episode 182 – we cover beauty questions about BB glow facials The safety of self tanners Doing you own research and Hard water and your beauty products Beauty Science News Butt Masks Is natural deodorant necessary ? So, with the uncertain safety profile and the limited benefit I’m not sure I can recommend doing this.

Safety 40

Safety Facials Injections Ingredients 40

Aesthetic Advancements Institute (AAI)

OCTOBER 18, 2023

Enter Percutaneous Collagen Induction (PCI) – a transformative treatment that’s catching the eyes of dermatologists and patients alike. microneedling market has seen a consistent upward trajectory since 2020, translating to more informed and effective treatments by practitioners. With Acne being a prime concern, the U.S.

Scarring 36

Scarring Microneedling Treatments Collagen 36

The Dermatology Digest

APRIL 23, 2024

Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) in response to Abeona’s Biologics License Application (BLA) for pz-cel for the treatment of patients with recessive dystrophic epidermolysis bullosa (RDEB).

Marketing 36

Marketing Safety Clinic Sustainability 36

Maxine Drake

OCTOBER 27, 2023

Each day, you strive to provide your clients with exceptional experiences that leave them feeling incredibly happy with the results of products and treatments. This information forms the basis for creating personalized treatment plans. Impeccable Hygiene and Safety Hygiene and safety are non-negotiable in our industry.

Esthetics 52

Esthetics Customer Service Safety Consultations 52

The Dermatology Digest

FEBRUARY 26, 2024

Sonelokimab is a novel investigational nanobody for the treatment of inflammatory disease. Marketing Authorization Application. European Medicines Agency (EMA) have greenlighted MoonLake Immunotherapeutics’ Phase 3 Program for the nanobody sonelokimab (SLK) in hidradenitis suppurativa (HS).

Office 74

Office Clinic Safety Innovations 74

NIMA Institute

JUNE 30, 2023

As the demand for non-surgical cosmetic treatments like Botox and dermal fillers continues to rise, the need for skilled professionals who can administer these procedures safely and effectively is greater than ever. Safety and Ethical Practices: Nima places a strong emphasis on safety and ethical practices in Botox and filler administration.

Training 52

Training Medical Esthetics Ethics Esthetics 52

Spa Executive

JULY 17, 2024

Offering a full spectrum of services, from design and brand development to recruiting, marketing, and day-to-day operations, Arch Amenities Group transforms key areas into activated, profitable spaces. This adaptability is ideal for residential spas seeking to optimize their treatment offerings while catering to varying client needs.

Technology 98

Technology Hospital Sustainability Innovations 98

The Dermatology Digest

MARCH 22, 2024

1,2 Benzene has become a more recent focus of attention related to safety concerns, with an increase in independent product testing and also updated regulations by the Food and Drug Administration related to benzene. Public safety is the first priority of the AARS.

Rosacea 64

Rosacea Document Safety Ingredients 64

The Dermatology Digest

DECEMBER 13, 2024

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion and recommended granting marketing authorization for nemolizumab (Nemluvio. Galderma) for the treatment of both atopic dermatitis and prurigo nodularis in the European Union (EU).

Dermatitis 36

Dermatitis Safety Marketing Therapy 36

The Dermatology Digest

JUNE 14, 2024

Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD. ICP-332 achieved multiple efficacy endpoints in the China Phase II study of patients with moderate-to-severe AD and demonstrated an “outstanding” and safety profile.

Dermatitis 36

Dermatitis Marketing Safety Innovations 36

The Dermatology Digest

SEPTEMBER 30, 2024

Otulfi is approved for the treatment of Crohn’s disease, ulcerative colitis, moderate to severe plaque psoriasis and active psoriatic arthritis. market, is an important milestone on our pathway to consistently broadening our biopharma portfolio in the U.S. This marks the fourth FDA-approved biosimilar for Stelara. and worldwide.

Portfolios 36

Portfolios Partnerships Marketing Safety 36

The Dermatology Digest

FEBRUARY 27, 2024

While both low-concentration and high-concentration strength biosimilars of Humira are marketed in the U.S. “Biosimilars create opportunities for cost savings across the healthcare system and introduce additional treatment options for patients. Both Alvotech and Teva expect to launch SIMLANDI in the U.S. today, nearly 88% of U.S.

Safety 36

Safety Marketing Pharmaceutical Partnerships 36

The Dermatology Digest

JULY 22, 2024

“Launching Uzpruvo at the earliest opportunity in Europe’s largest pharmaceutical markets, promotes access by creating competition,” says STADA CEO Peter Goldschmidt in a news release. We are delighted at the launch of Uzpruvo in Europe and to be first-to-market,” adds Robert Wessman, Chief Executive Officer of Alvotech.

Partnerships 36

Partnerships Pharmaceutical Marketing Office 36

The Dermatology Digest

MAY 23, 2024

Food and Drug Administration accepted for review the supplemental biologics license application for bimekizumab-bkzx for the treatment of adults with moderate-to-severe HS. Other regulatory submissions for bimekizumab-bkzx in the treatment of moderate-to-severe hidradenitis suppurativa are underway around the world.

Sustainability 36

Sustainability Safety Clinic Medical 36

The Dermatology Digest

FEBRUARY 16, 2024

The Ministry of Health, Labor and Welfare (MHLW) in Japan has granted marketing and manufacturing authorization for dupilumab (Dupixent, Sanofi and Regeneron Pharmaceuticals, Inc.) for the treatment of chronic spontaneous urticaria (CSU) in people aged 12 years and older whose disease is not adequately controlled with existing therapy.

Pharmaceutical 36

Pharmaceutical Safety Dermatitis Therapy 36

Style Seat - Business Growth

JULY 23, 2024

Consider your target market as well. Understanding your target audience will help you tailor your services, pricing, and marketing strategies to attract and retain clients. Develop a comprehensive business plan With your spa concept and target market in mind, it’s time to create a detailed business plan.

Legal 40

Legal Customer Service Sanitation Marketing 40

Style Seat - Business Growth

JULY 23, 2024

Consider your target market as well. Understanding your target audience will help you tailor your services, pricing, and marketing strategies to attract and retain clients. Develop a comprehensive business plan With your spa concept and target market in mind, it’s time to create a detailed business plan.

Legal 40

Legal Customer Service Sanitation Marketing 40